| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/12/2000 | EP0970236A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media |
| 01/12/2000 | EP0970233A1 Methods and compositions for genetically modifying primate bone marrow cells |
| 01/12/2000 | EP0970232A2 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 01/12/2000 | EP0970231A1 Expression of herbicide-binding polypeptides in plants to produce herbicide tolerance |
| 01/12/2000 | EP0970230A1 Improved sar plant transformation process |
| 01/12/2000 | EP0970229A1 Genetically transformed plants demonstrating resistance to porphyrinogen biosynthesis-inhibiting herbicides |
| 01/12/2000 | EP0970228A1 Methods and means for gene silencing in transgenic plants |
| 01/12/2000 | EP0970227A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/12/2000 | EP0970226A1 Vectors having enhanced expression, and methods of making and uses thereof |
| 01/12/2000 | EP0970225A1 Improved metallo-endopeptidases |
| 01/12/2000 | EP0970224A1 Recombinant haloaliphatic dehalogenases |
| 01/12/2000 | EP0970223A1 Serine/threonine protein kinase |
| 01/12/2000 | EP0970222A1 Method for modulating the biomass of plants |
| 01/12/2000 | EP0970221A1 Selection method for transgenic plants |
| 01/12/2000 | EP0970220A1 Method for producing non-infectious recombinant picornavirus particles |
| 01/12/2000 | EP0970219A1 A porin gene from campylobacter jejuni, related products and uses thereof |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970217A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
| 01/12/2000 | EP0970216A1 TRANSGENIC MICE EXPRESSING THE $i(H/K-RAS 4B) CHIMERIC GENE |
| 01/12/2000 | EP0970215A1 Suppressor of cytokine signaling |
| 01/12/2000 | EP0970214A1 Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene |
| 01/12/2000 | EP0970213A2 Death domain containing receptor 5 |
| 01/12/2000 | EP0970212A1 Secreted salivary zsig32 polypeptides |
| 01/12/2000 | EP0970211A1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 01/12/2000 | EP0970210A1 Methods of modulating p33ing1 mediated apoptosis |
| 01/12/2000 | EP0970209A1 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970208A1 Sp$g(a): A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 01/12/2000 | EP0970207A1 Heregulin variants |
| 01/12/2000 | EP0970206A1 Lage-1 tumor associated nucleic acids |
| 01/12/2000 | EP0970205A2 Human endosulfine gene |
| 01/12/2000 | EP0970204A1 Novel gene encoding male-transplantation antigen |
| 01/12/2000 | EP0970203A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 01/12/2000 | EP0970202A2 Characterization of the yeast transcriptome |
| 01/12/2000 | EP0970201A1 Retroviral vectors capable of transducing non-dividing cells |
| 01/12/2000 | EP0970200A2 Method for enhancing expression of a foreign or endogenous gene product in plants |
| 01/12/2000 | EP0970198A2 Novel compounds |
| 01/12/2000 | EP0970195A1 Fatty-acid amide hydrolase |
| 01/12/2000 | EP0970193A1 PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY |
| 01/12/2000 | EP0970192A1 NUCLEIC ACID ENCODING $i(M. TUBERCULOSIS) ALGU PROTEIN |
| 01/12/2000 | EP0970190A1 Isolated viable parasite intestinal cells |
| 01/12/2000 | EP0970187A1 Pituitary differentiation factor and methods of use thereof |
| 01/12/2000 | EP0970186A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 01/12/2000 | EP0970185A1 Insecticidal protein toxins from $i(photorhabdus) |
| 01/12/2000 | EP0970128A1 Immunotherapeutic ctla-4 binding peptides |
| 01/12/2000 | EP0970127A1 Antibody variants |
| 01/12/2000 | EP0970126A2 Method for the production of antihuman antigen receptors and uses thereof |
| 01/12/2000 | EP0970125A2 Histidine decarboxylase immunoreactivity to detect cancer |
| 01/12/2000 | EP0970124A2 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
| 01/12/2000 | EP0970122A1 Human anion channel |
| 01/12/2000 | EP0970120A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 01/12/2000 | EP0970119A1 Synaptic activation protein compositions and method |
| 01/12/2000 | EP0970115A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970108A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970102A1 Antisense inhibition of angiogenin expression |
| 01/12/2000 | EP0970101A2 Solvent for biopolymer synthesis, solvent microdroplets and methods of use |
| 01/12/2000 | EP0969876A2 Delivery system for gene therapy to the brain |
| 01/12/2000 | EP0969875A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 01/12/2000 | EP0969865A1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 01/12/2000 | EP0969864A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 01/12/2000 | EP0969862A2 SYNTHETIC HIV $i(GAG) GENES |
| 01/12/2000 | EP0969861A1 Inhibiting hiv infection by cleaving co-receptor rna |
| 01/12/2000 | EP0969858A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 01/12/2000 | EP0969855A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 01/12/2000 | EP0969716A1 Endometriosis mouse model |
| 01/12/2000 | EP0969714A1 Rg nucleic acids for conferring disease resistance to plants |
| 01/12/2000 | EP0846167A4 Nuclear-encoded transcription system in plastids of higher plants |
| 01/12/2000 | EP0843738B1 Nucleic acid detection method using nucleotide probes enabling both specific capture and detection |
| 01/12/2000 | EP0770142B1 Method for increasing the sensitivity of detecting nucleic acid-probe target hybrids |
| 01/12/2000 | EP0725837B1 Adeno-associated virus - its diagnostic use with early abortion |
| 01/12/2000 | EP0594764B1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/12/2000 | EP0572401B1 Viral particles having altered host range |
| 01/12/2000 | EP0552358B1 Oligonucleotides complementary to mycobacterial nucleic acids |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/12/2000 | CN1241216A Non-mammalian DNA virus having altered coat protein |
| 01/12/2000 | CN1241215A Method of using VIM1 gene to confer disease resistance in plants |
| 01/12/2000 | CN1241214A Microbial preparation of substances from aromatic metabolism/I |
| 01/12/2000 | CN1241213A Bacillus thuringiensis Cry ET 33 and Cry ET 34 compositions and uses therefor |
| 01/12/2000 | CN1241212A Compound and methods for immunotherapy and diagnosis of tuberculosis |
| 01/12/2000 | CN1241211A Recombination in vivo |
| 01/12/2000 | CN1241193A Meningococcus vaccine comprising valence of BZ23 strain |
| 01/12/2000 | CN1240830A High-efficiency expression of artificially synthetic interferon alpha-2b gene in colibacillus |
| 01/12/2000 | CN1240829A Optimization method for activation of endogenetic gene of cell |
| 01/12/2000 | CN1048254C Compound for introduction of prospective change in target gene |
| 01/11/2000 | US6013864 Vector coding a viral polymerase enzyme which helps prevent viral infection of plants |
| 01/11/2000 | US6013863 Fertile transgenic corn plants |
| 01/11/2000 | US6013862 Wheat aleurone regulatory elements |
| 01/11/2000 | US6013861 Producing a cereal plant which has a vector incorporated into its genome which codes for enzymes involved in glycogen or starch biosynthesis and less sensitivity to increased temperature ranges |
| 01/11/2000 | US6013860 Vector coding a microorganism cellulase enzyme; for the production in organelles of cellulose degrading enzymes |
| 01/11/2000 | US6013859 Molecular methods of hybrid seed production |
| 01/11/2000 | US6013858 Mouse lacking heart-muscle adenine nucleotide translocator protein and methods |
| 01/11/2000 | US6013857 Milk produced by a hybrid cattle whose genome comprises a chimeric gene encoding a recombinant heterologous polypeptide that is recovered from milk |
| 01/11/2000 | US6013788 Antisense modulation of Smad3 expression |
| 01/11/2000 | US6013787 Antisense modulation of Smad4 expression |
| 01/11/2000 | US6013786 Nucleotide sequences used as inhibitors of the oncogenic action of the encoded protein; antitumor agents |
| 01/11/2000 | US6013785 Polynucleoside chain having multiple ribonucleosides, the nucleosides coupled by guanidyl linkages |
| 01/11/2000 | US6013784 Nucleic acids encoding HST 2 muteins |
| 01/11/2000 | US6013783 Boronic acid containing oligonucleotides and polynucleotides |